Avalo Therapeutics, Inc. (AVTX) Total assets 2016–2025
Avalo Therapeutics, Inc. (AVTX) total assets at each fiscal year-end, per SEC filings.
$116.5MFY2025 · since FY2016: $5.8M → $116.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $116.5M | -22.7% |
| FY2024 | $150.7M | +618.0% |
| FY2023 | $21.0M | -37.1% |
| FY2022 | $33.4M | -58.4% |
| FY2021 | $80.2M | +83.3% |
| FY2020 | $43.8M | +21.2% |
| FY2019 | $36.1M | -48.6% |
| FY2018 | $70.3M | +64.1% |
| FY2017 | $42.8M | +642.0% |
| FY2016 | $5.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice